These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2357268

  • 1. Neuromelanin synthesis in rat and human substantia nigra.
    Rabey JM, Hefti F.
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):1-14. PubMed ID: 2357268
    [Abstract] [Full Text] [Related]

  • 2. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Nature; 1990; 327(6120):324-6. PubMed ID: 2884568
    [Abstract] [Full Text] [Related]

  • 3. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ, Lipman ZP, Snyder SH.
    Science; 1986 Feb 28; 231(4741):987-9. PubMed ID: 3080808
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
    D'Amato RJ, Benham DF, Snyder SH.
    J Neurochem; 1987 Feb 28; 48(2):653-8. PubMed ID: 3491879
    [Abstract] [Full Text] [Related]

  • 5. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y.
    Neuroscience; 1993 Sep 28; 56(2):499-511. PubMed ID: 8247275
    [Abstract] [Full Text] [Related]

  • 6. Neuromelanin: a role in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Life Sci; 1987 Feb 23; 40(8):705-12. PubMed ID: 2880274
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I, Langston JW.
    Life Sci; 1985 Jan 21; 36(3):207-12. PubMed ID: 3871240
    [Abstract] [Full Text] [Related]

  • 11. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M, Little MD, Bankiewicz K, Yang SC, Markey SP, Johannessen JN.
    Neuroscience; 1991 Jan 21; 40(1):133-58. PubMed ID: 2052148
    [Abstract] [Full Text] [Related]

  • 12. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 21; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 13. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW.
    Brain Res; 1987 Feb 10; 403(1):43-51. PubMed ID: 3493827
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Feb 10; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 15. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H, Arai Y, Toyoshima Y.
    Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524
    [Abstract] [Full Text] [Related]

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
    Ito T, Suzuki K, Uchida K, Nakayama H.
    Exp Toxicol Pathol; 2012 Nov 31; 64(7-8):761-5. PubMed ID: 21324658
    [Abstract] [Full Text] [Related]

  • 17. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
    Trevor AJ, Singer TP, Ramsay RR, Castagnoli N.
    J Neural Transm Suppl; 1987 Nov 31; 23():73-89. PubMed ID: 3295117
    [Abstract] [Full Text] [Related]

  • 18. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
    Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D.
    Mol Pathol; 2001 Dec 31; 54(6):414-8. PubMed ID: 11724917
    [Abstract] [Full Text] [Related]

  • 19. Neuromelanin of the human substantia nigra: an update.
    Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L.
    Neurotox Res; 2014 Jan 31; 25(1):13-23. PubMed ID: 24155156
    [Abstract] [Full Text] [Related]

  • 20. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.
    Snyder SH, D'Amato RJ.
    Neurology; 1986 Feb 31; 36(2):250-8. PubMed ID: 3080696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.